A.R.T. Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-198,100
| Closed | -$2.46M | – | 1925 |
|
|
2016
Q4 | $2.46M | Buy |
+198,100
| New | +$2.39M | 0.15% | 198 |
|
|
2016
Q3 | – | Sell |
-438,817
| Closed | -$3.24M | – | 1510 |
|
|
2016
Q2 | $3.24M | Buy |
+438,817
| New | +$3.29M | 0.16% | 166 |
|
|
2016
Q1 | – | Sell |
-281,552
| Closed | -$1.76M | – | 1861 |
|
|
2015
Q4 | $1.76M | Buy |
+281,552
| New | +$1.85M | 0.08% | 337 |
|
|
2015
Q3 | – | Sell |
-221,003
| Closed | -$1.83M | – | 1799 |
|
|
2015
Q2 | $1.83M | Sell |
221,003
-58,264
| -21% | -$515K | 0.06% | 487 |
|
|
2015
Q1 | $2.3M | Buy |
+279,267
| New | +$2.06M | 0.08% | 341 |
|
|
2014
Q4 | – | Sell |
-120,670
| Closed | -$651K | – | 1836 |
|
|
2014
Q3 | $651K | Buy |
+120,670
| New | +$705K | 0.03% | 654 |
|
|
2014
Q2 | – | Sell |
-568,559
| Closed | -$4.58M | – | 1690 |
|
|
2014
Q1 | $4.58M | Buy |
+568,559
| New | +$4.43M | 0.24% | 100 |
|
|
2013
Q4 | – | Sell |
-183,377
| Closed | -$3.37M | – | 1698 |
|
|
2013
Q3 | $3.37M | Buy |
+183,377
| New | +$3.56M | 0.18% | 144 |
|
Other funds holding ARIA
A.R.T. Advisors's ARIA Position: Q1 2017 in Review
A.R.T. Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 198,100 shares — an estimated $2.46M sold.
A.R.T. Advisors first reported a position in ARIA in Q3 2013 and held it in 8 quarters. The position peaked at $4.58M in Q1 2014. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- A.R.T. Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- A.R.T. Advisors sold 198,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.46M.
- A.R.T. Advisors first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
- A.R.T. Advisors's Ariad Pharmaceuticals Inc position peaked at $4.58M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on A.R.T. Advisors's 13F filing for Q1 2017, filed 15 May 2017.